MASSIMI, DAVIDE
MASSIMI, DAVIDE
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study
2021 Barberio, B.; Cingolani, L.; Canova, C.; Barbieri, G.; Sablich, R.; Urbano, M. T.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Ferronato, A.; Buda, A.; Melatti, P.; Massimi, D.; Savarino, E. V.; Zingone, F.
A specific microbiota signature is associated to various degrees of ulcerative colitis as assessed by a machine learning approach
2022 Barberio, B.; Facchin, S.; Patuzzi, I.; Ford, A. C.; Massimi, D.; Valle, G.; Sattin, E.; Simionati, B.; Bertazzo, E.; Zingone, F.; Savarino, E. V.
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator
2021 Cingolani, L.; Barberio, B.; Zingone, F.; Ferronato, A.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Melatti, P.; Gubbiotti, A.; Massimi, D.; Casadei, C.; D'Inca, R.; Savarino, E. V.
Faecal microbiota transplantation in Clostridioides difficile infection: real-life experience from an academic Italian hospital
2020 Barberio, B.; Facchin, S.; Mele, E.; D'Inca, R.; Sturniolo, G. C.; Farinati, F.; Zingone, F.; Quagliariello, A.; Ghisa, M.; Massimi, D.; Casadei, C.; Savarino, E. V.
Fecal microbiota transplantation for norovirus infection: a clinical and microbiological success.
2020 Barberio, Brigida; Massimi, Davide; Bonfante, Luciana; Facchin, Sonia; Calo', Lorenzo; Trevenzoli, Massimo; Savarino, EDOARDO VINCENZO; Anna Maria, Cattelan
Incidence comparison of adverse events in patients with inflammatory bowel disease receiving different biologic agents: retrospective long-term evaluation
2021 Barberio, Brigida; Savarino, Edoardo Vincenzo; Card, Timothy; Canova, Cristina; Baldisser, Francesco; Gubbiotti, Alessandro; Massimi, Davide; Ghisa, Matteo; Zingone, Fabiana
Infliximab Originator, Infliximab Biosimilar, and Adalimumab Are More Effective in Crohn's Disease Than Ulcerative Colitis: A Real-Life Cohort Study
2020 Barberio, B.; Zingone, F.; D'Inca, R.; Rovigo, L.; Bertani, L.; Bodini, G.; Ghisa, M.; Gubbiotti, A.; Massimi, D.; Lorenzon, G.; Savarino, E. V.
Medical and gastroenterological education during the COVID-19 outbreak
2020 Barberio, Brigida; Massimi, Davide; Dipace, Anna; Zingone, Fabiana; Farinati, Fabio; Savarino, Edoardo V
Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
2021 Barberio, Brigida; Massimi, Davide; Cazzagon, Nora; Zingone, Fabiana; Ford, Alexander C; Savarino, Edoardo V
REAL LIFE COMPARISON OF DIFFERENT ANTI-TNF BIOLOGIC THERAPIES FOR ULCERATIVE COLITIS TREATMENT: A RETROSPECTIVE COHORT STUDY
2020 Barberio, Brigida; Zingone, Fabiana; Frazzoni, Leonardo; D''Incà, Renata; Maccarone, Maria Chiara; Ghisa, Matteo; Massimi, Davide; Lorenzon, Greta; Savarino, Edoardo
Serum Levels of PCSK9 Are Increased in Patients With Active Ulcerative Colitis Representing a Potential Biomarker of Disease Activity: A Cross-sectional Study
2021 Marinelli, Carla; Zingone, Fabiana; Lupo, Maria Giovanna; Marin, Raffaella; D'Incà, Renata; Gubbiotti, Alessandro; Massimi, Davide; Casadei, Cesare; Barberio, Brigida; Ferri, Nicola; Savarino, Edoardo
Switching from Infliximab Originator to SB2 Biosimilar in Inflammatory Bowel Diseases: A Multicentric Prospective Real-Life Study
2021 Massimi, D.; Barberio, B.; Bertani, L.; Costa, F.; Ferronato, A.; Facchin, S.; Cardin, R.; Cingolani, L.; Casadei, C.; D'Inca, R.; Zingone, F.; Savarino, E. V.